Revascularization versus medical therapy for the treatment of stable coronary artery disease: A meta-analysis of contemporary randomized controlled trials

被引:19
作者
Laukkanen, Jari A. [1 ,2 ,3 ]
Kunutsor, Setor K. [4 ,5 ,6 ]
机构
[1] Univ Eastern Finland, Inst Clin Med, Dept Med, POB 1627, FIN-70211 Kuopio, Finland
[2] Cent Finland Hlth Care Dist, Dept Med, Jyvaskyla, Finland
[3] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland
[4] Univ Hosp Bristol & Weston NHS Fdn Trust, Bristol Biomed Res Ctr, Natl Inst Hlth Res, Bristol, Avon, England
[5] Univ Bristol, Bristol, Avon, England
[6] Univ Bristol, Bristol Med Sch, Translat Hlth Sci, Southmead Hosp, Learning & Res Bldg Level 1, Bristol, Avon, England
关键词
Revascularization; Percutaneous coronary intervention; Coronary-artery bypass grafting; Medical therapy; Coronary artery disease; Meta-analysis; CONTROLLED CLINICAL-TRIAL; ST-SEGMENT ELEVATION; MYOCARDIAL-INFARCTION; MASS-II; TASK-FORCE; FOLLOW-UP; ANGIOPLASTY; INTERVENTION; MANAGEMENT; SURGERY;
D O I
10.1016/j.ijcard.2020.10.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We conducted a systematic review and meta-analysis of contemporary randomized controlled trials (RCTs) to compare clinical outcomes among stable coronary artery disease (CAD) patients treated with revascularization [percutaneous coronary intervention (PCI), coronary-artery bypass grafting (CABG) or both] plus medical therapy (MT) versus MT alone. Methods: Prospective RCTs were sought from MEDLINE, Embase, The Cochrane Library, and Web of Science up to April 2020. Data was extracted on study characteristics, methods, and outcomes. Relative risks (RRs) with 95% confidence intervals (CIs) were pooled for the composite of all-cause mortality, myocardial infarction (MI), revascularizations, rehospitalizations, or stroke; its individual components and other cardiovascular endpoints. Results: Twelve unique RCTs comprising of 15,774 patients were included. There was no significant difference in all-cause mortality risk (0.95, 95% CI: 0.86-1.06); however, revascularization plus MT reduced the risk of the composite outcome of all-cause mortality, MI, revascularizations, rehospitalizations, or stroke (0.69, 95% CI: 0.55-0.87); unplanned revascularization (0.53, 95% CI: 0.40-0.71); and fatal MI (0.65, 95% CI: 0.49-0.84). Revascularization plus MT reduced the risk of stroke at 1 year (0.44, 95% CI: 0.30-0.65) and unplanned revascularization and the composite outcome of all-cause mortality, MI, revascularizations, rehospitalizations, or stroke at 2-5 years. Conclusions: Revascularization plus MT does not confer survival advantage beyond that of MT among patients with stable CAD. However, revascularization plus MT may reduce the overall risk of the combined outcome of mortality, MI, revascularizations, rehospitalizations, or stroke, which could be driven by a decrease in the risk of unplanned revascularizations or fatal MI. (C) 2020 Elsevier B.V. All rights reserved.Y
引用
收藏
页码:13 / 21
页数:9
相关论文
共 41 条
[1]   Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial [J].
Al-Lamee, Rasha ;
Thompson, David ;
Dehbi, Hakim-Moulay ;
Sen, Sayan ;
Tang, Kare ;
Davies, John ;
Keeble, Thomas ;
Mielewczik, Michael ;
Kaprielian, Raffi ;
Malik, Iqbal S. ;
Nijjer, Sukhjinder S. ;
Petraco, Ricardo ;
Cook, Christopher ;
Ahmad, Yousif ;
Howard, James ;
Baker, Christopher ;
Sharp, Andrew ;
Gerber, Robert ;
Talwar, Suneel ;
Assomull, Ravi ;
Mayet, Jamil ;
Wensel, Roland ;
Collier, David ;
Shun-Shin, Matthew ;
Thom, Simon A. ;
Davies, Justin E. ;
Francis, Darrel P. .
LANCET, 2018, 391 (10115) :31-40
[2]   A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease [J].
Frye R.L. ;
August P. ;
Brooks M.M. ;
Hardison R.M. ;
Kelsey S.F. ;
MacGregor J.M. ;
Orchard T.J. ;
Chaitman B.R. ;
Genuth S.M. ;
Goldberg S.H. ;
Hlatky M.A. ;
Jones T.L.Z. ;
Molitch M.E. ;
Nesto R.W. ;
Sako E.Y. ;
Sobel B.E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (24) :2503-2515
[3]   Optimal medical therapy with or without PCI for stable coronary disease [J].
Boden, William E. ;
O'Rourke, Robert A. ;
Teo, Koon K. ;
Hartigan, Pamela M. ;
Maron, David J. ;
Kostuk, William J. ;
Knudtson, Merril ;
Dada, Marcin ;
Casperson, Paul ;
Harris, Crystal L. ;
Chaitman, Bernard R. ;
Shaw, Leslee ;
Gosselin, Gilbert ;
Nawaz, Shah ;
Title, Lawrence M. ;
Gau, Gerald ;
Blaustein, Alvin S. ;
Booth, David C. ;
Bates, Eric R. ;
Spertus, John A. ;
Berman, Daniel S. ;
Mancini, G. B. John ;
Weintraub, William S. ;
Boden, W. ;
O'Rourke, R. ;
Teo, K. ;
Hartigan, P. ;
Weintraub, W. ;
Maron, D. ;
Mancini, J. ;
Weintraub, W. ;
Boden, W. ;
O'Rourke, R. ;
Teo, K. ;
Hartigan, P. ;
Knudtson, M. ;
Maron, D. ;
Bates, E. ;
Blaustein, A. ;
Booth, D. ;
Carere, R. ;
Ellis, S. ;
Gosselin, G. ;
Gau, G. ;
Jacobs, A. ;
King, S., III ;
Kostuk, W. ;
Harris, C. ;
Spertus, J. ;
Peduzzi, P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (15) :1503-1516
[4]   5-Year Clinical Outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) Trial A Randomized Comparison of an Early Invasive Versus Selective Invasive Management in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome [J].
Damman, Peter ;
Hirsch, Alexander ;
Windhausen, Fons ;
Tijssen, Jan G. P. ;
de Winter, Robbert J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (09) :858-864
[5]   Fractional Flow Reserve-Guided PCI versus Medical Therapy in Stable Coronary Disease [J].
De Bruyne, Bernard ;
Pijls, Nico H. J. ;
Kalesan, Bindu ;
Barbato, Emanuele ;
Tonino, Pim A. L. ;
Piroth, Zsolt ;
Jagic, Nikola ;
Mobius-Winckler, Sven ;
Rioufol, Gilles ;
Witt, Nils ;
Kala, Petr ;
MacCarthy, Philip ;
Engstrom, Thomas ;
Oldroyd, Keith G. ;
Mavromatis, Kreton ;
Manoharan, Ganesh ;
Verlee, Peter ;
Frobert, Ole ;
Curzen, Nick ;
Johnson, Jane B. ;
Jueni, Peter ;
Fearon, William F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (11) :991-1001
[6]   Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634
[7]   Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial [J].
Engstrom, Thomas ;
Kelbaek, Henning ;
Helqvist, Steffen ;
Hofsten, Dan Eik ;
Klovgaard, Lene ;
Holmvang, Lene ;
Jorgensen, Erik ;
Pedersen, Frants ;
Saunamaki, Kari ;
Clemmensen, Peter ;
De Backer, Ole ;
Ravkilde, Jan ;
Tilsted, Hans-Henrik ;
Villadsen, Anton Boel ;
Aaroe, Jens ;
Jensen, Svend Eggert ;
Raungaard, Bent ;
Kober, Lars .
LANCET, 2015, 386 (9994) :665-671
[8]   2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease [J].
Fihn, Stephan D. ;
Blankenship, James C. ;
Naidu, Srihari S. ;
Ohman, E. Magnus ;
Smith, Peter K. ;
Alexander, Karen P. ;
Bittl, John A. ;
Byrne, John G. ;
Fletcher, Barbara J. ;
Fonarow, Gregg C. ;
Lange, Richard A. ;
Levine, Glenn N. ;
Maddox, Thomas M. ;
Anderson, Jeffrey L. ;
Halperin, Jonathan L. ;
Albert, Nancy M. ;
Bozkurt, Biykem ;
Brindis, Ralph G. ;
Curtis, Lesley H. ;
DeMets, David ;
Guyton, Robert A. ;
Hochman, Judith S. ;
Kovacs, Richard J. ;
Pressler, Susan J. ;
Sellke, Frank W. ;
Shen, Win-Kuang .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (18) :1929-1949
[9]   Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease -: A randomized trial [J].
Hambrecht, R ;
Walther, C ;
Möbius-Winkler, S ;
Gielen, S ;
Linke, A ;
Conradi, K ;
Erbs, S ;
Kluge, R ;
Kendziorra, K ;
Sabri, O ;
Schuler, G .
CIRCULATION, 2004, 109 (11) :1371-1378
[10]   Seven-year outcome in the RITA-2 trial: Coronary angioplasty versus medical therapy [J].
Henderson, RA ;
Pocock, SJ ;
Clayton, TC ;
Knight, R ;
Fox, KAA ;
Julian, DG ;
Chamberlain, DA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (07) :1161-1170